Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Timothy E. Benson is active.

Publication


Featured researches published by Timothy E. Benson.


Nature Structural & Molecular Biology | 2011

Structural Basis of Substrate Discrimination and Integrin Binding by Autotaxin.

Jens Hausmann; Satwik Kamtekar; Evangelos Christodoulou; Jacqueline E. Day; Tao Wu; Zachary Fulkerson; Harald M. H. G. Albers; Laurens A. van Meeteren; Anna J. S. Houben; Leonie van Zeijl; Silvia Jansen; Maria Andries; Troii Hall; Lyle E. Pegg; Timothy E. Benson; Mobien Kasiem; Karl Harlos; Craig W. Vander Kooi; Susan S. Smyth; Huib Ovaa; Mathieu Bollen; Andrew J. Morris; Wouter H. Moolenaar; Anastassis Perrakis

Autotaxin (ATX, also known as ectonucleotide pyrophosphatase/phosphodiesterase-2, ENPP2) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types. ATX-LPA signaling is involved in various pathologies including tumor progression and inflammation. However, the molecular basis of substrate recognition and catalysis by ATX and the mechanism by which it interacts with target cells are unclear. Here, we present the crystal structure of ATX, alone and in complex with a small-molecule inhibitor. We have identified a hydrophobic lipid-binding pocket and mapped key residues for catalysis and selection between nucleotide and phospholipid substrates. We have shown that ATX interacts with cell-surface integrins through its N-terminal somatomedin B–like domains, using an atypical mechanism. Our results define determinants of substrate discrimination by the ENPP family, suggest how ATX promotes localized LPA signaling and suggest new approaches for targeting ATX with small-molecule therapeutic agents.


Journal of Molecular Biology | 2010

Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6.

Jill E. Chrencik; Akshay Patny; Iris K. Leung; Brian Korniski; Thomas L. Emmons; Troii Hall; Robin A. Weinberg; Jennifer A. Gormley; Jennifer M. Williams; Jacqueline E. Day; Jeffrey L. Hirsch; James R. Kiefer; Joseph W. Leone; H. David Fischer; Cynthia D. Sommers; Horng-Chih Huang; E.J. Jacobsen; Ruth E. Tenbrink; Alfredo G. Tomasselli; Timothy E. Benson

Janus kinases (JAKs) are critical regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases. Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clinical compound CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding. Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isozymes in orientations similar to that observed in crystal structures of JAK1 and JAK2. Additionally, a complete thermodynamic characterization of JAK/CP-690550 complex formation was completed by isothermal titration calorimetry, indicating the critical role of the nitrile group from the CP-690550 compound. Finally, computational analysis using WaterMap further highlights the critical positioning of the CP-690550 nitrile group in the displacement of an unfavorable water molecule beneath the glycine-rich loop. Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isozyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isozymes. Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isozyme selective inhibitors.


Journal of Molecular Biology | 2010

Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation

Mauro Mileni; Satwik Kamtekar; David C. Wood; Timothy E. Benson; Benjamin F. Cravatt; Raymond C. Stevens

The endocannabinoid system regulates a wide range of physiological processes including pain, inflammation, and cognitive/emotional states. URB597 is one of the best characterized covalent inhibitors of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH). Here, we report the structure of the FAAH-URB597 complex at 2.3 A resolution. The structure provides insights into mechanistic details of enzyme inactivation and experimental evidence of a previously uncharacterized active site water molecule that likely is involved in substrate deacylation. This water molecule is part of an extensive hydrogen-bonding network and is coordinated indirectly to residues lining the cytosolic port of the enzyme. In order to corroborate our hypothesis concerning the role of this water molecule in FAAHs catalytic mechanism, we determined the structure of FAAH conjugated to a urea-based inhibitor, PF-3845, to a higher resolution (2.4 A) than previously reported. The higher-resolution structure confirms the presence of the water molecule in a virtually identical location in the active site. Examination of the structures of serine hydrolases that are non-homologous to FAAH, such as elastase, trypsin, or chymotrypsin, shows a similarly positioned hydrolytic water molecule and suggests a functional convergence between the amidase signature enzymes and serine proteases.


Journal of Biological Chemistry | 2008

High Resolution Crystal Structure of the Catalytic Domain of ADAMTS-5 (Aggrecanase-2)

Huey-Sheng Shieh; Karl J. Mathis; Jennifer M. Williams; Robert Hills; Joe F. Wiese; Timothy E. Benson; James R. Kiefer; Margaret H. Marino; Jeffery N. Carroll; Joseph W. Leone; Anne-Marie Malfait; Elizabeth C. Arner; Micky D. Tortorella; Alfredo G. Tomasselli

Aggrecanase-2 (a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5)), a member of the ADAMTS protein family, is critically involved in arthritic diseases because of its direct role in cleaving the cartilage component aggrecan. The catalytic domain of aggrecanase-2 has been refolded, purified, and crystallized, and its three-dimensional structure determined to 1.4Å resolution in the presence of an inhibitor. A high resolution structure of an ADAMTS/aggrecanase protein provides an opportunity for the development of therapeutics to treat osteoarthritis.


Bioorganic & Medicinal Chemistry Letters | 2007

Design of potent inhibitors of human beta-secretase. Part 2.

John N. Freskos; Yvette M. Fobian; Timothy E. Benson; Joseph B. Moon; Michael J. Bienkowski; David L. Brown; Thomas L. Emmons; Robert M. Heintz; Alice Laborde; Joseph J. Mcdonald; Brent V. Mischke; John M. Molyneaux; Patrick B. Mullins; D. Bryan Prince; Donna J. Paddock; Alfredo G. Tomasselli; Greg Winterrowd

We describe an optimized series of acyclic hydroxyethylamine transition state isosteres of beta-secretase that incorporates a variety of P(2) side chains that yield potent inhibitors with excellent cellular activity. A 2.2A crystal structure of compound 13 is shown.


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2010

Crystallization and preliminary X-ray diffraction analysis of rat autotaxin

Jacqueline E. Day; Troii Hall; Lyle E. Pegg; Timothy E. Benson; Jens Hausmann; Satwik Kamtekar

Rat autotaxin has been cloned, expressed, purified to homogeneity and crystallized via hanging-drop vapour diffusion using PEG 3350 as precipitant and ammonium iodide and sodium thiocyanate as salts. The crystals diffracted to a maximum resolution of 2.05 A and belonged to space group P1, with unit-cell parameters a=53.8, b=63.3, c=70.5 A, alpha=98.8, beta=106.2, gamma=99.8 degrees. Preliminary X-ray diffraction analysis indicated the presence of one molecule per asymmetric unit, with a solvent content of 47%.


Journal of Medicinal Chemistry | 2007

Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase†

Michel Maillard; Roy K. Hom; Timothy E. Benson; Joseph B. Moon; Shumeye S. Mamo; Michael J. Bienkowski; Alfredo G. Tomasselli; D. Danielle Woods; D. Bryan Prince; Donna J. Paddock; Thomas L. Emmons; John A. Tucker; Michael S. Dappen; Louis Brogley; Eugene D. Thorsett; Nancy Jewett; and Sukanto Sinha; Varghese John


Bioorganic & Medicinal Chemistry Letters | 2007

Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1

Steven W. Kortum; Timothy E. Benson; Michael J. Bienkowski; Thomas L. Emmons; D. Bryan Prince; Donna J. Paddock; Alfredo G. Tomasselli; Joseph B. Moon; Alice Laborde; Ruth E. Tenbrink


Bioorganic & Medicinal Chemistry Letters | 2007

Potent and selective isophthalamide S(2) hydroxyethylamine inhibitors of BACE1.

Steven W. Kortum; Timothy E. Benson; Michael J. Bienkowski; Thomas L. Emmons; D.B Prince; D.J Paddock; Alfredo G. Tomasselli; Joseph B. Moon; Alice Laborde; Ruth E. Tenbrink


Archive | 2005

Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease

Timothy E. Benson; Jim D. Durbin; Donald Bryan Prince

Collaboration


Dive into the Timothy E. Benson's collaboration.

Researchain Logo
Decentralizing Knowledge